Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC.

被引：0
|
作者：
Buosi, R [1 ]
Poletti, S [1 ]
Cantele, V [1 ]
Piazza, S [1 ]
Torazzo, R [1 ]
Negru, E [1 ]
Vandone, A [1 ]
Alabiso, O [1 ]
机构：
[1] Osped Maggiore La Carita, Novara, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7348
引用
收藏
页码：703S / 703S
页数：1
相关论文
共 50 条
  • [41] Preliminary results of a Phase II study of the combination of biweekly cisplatin (CDDP) and gemcitabine in patients with platinum refractory advanced ovarian carcinoma
    Efstathiou, Eleni
    ANNALS OF ONCOLOGY, 2004, 15 : 131 - 131
  • [42] Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): A multicenter phase II study
    Kakolyris, Stylianos
    Ziras, Nikolaos
    Vamvakas, Lambros
    Varthalitis, John
    Papakotoulas, Pavlos
    Syrigos, Kostas
    Vardakis, Nikolaos
    Kalykaki, Antonia
    Amarantidis, Kiriakos
    Georgoulias, Vassilis
    LUNG CANCER, 2006, 54 (03) : 347 - 352
  • [43] Phase II trial of gemcitabine-UFT-leucovorin (ILV) in advanced carcinoma of the pancreas:: Preliminary results
    Feliu, J
    Vincent, JM
    Dorta, J
    Constenla, M
    Espinosa, J
    Belón, J
    López-Gómez, L
    Fernández, Y
    de Castro, J
    Barón, MG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S156 - S157
  • [44] A phase II trial of cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer
    Loehr, J. M.
    Bodoky, G.
    Foelsch, U.
    Maerten, A.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 386 - 386
  • [45] Cationic liposomal paclitaxel in combination with gemcitabine in patients with advanced pancreatic cancer: A phase II trial
    Loehr, M.
    Bodoky, G.
    Folsch, U.
    Marten, A.
    Karrasch, M.
    Lilla, C.
    Meyer, I.
    Osinsky, D.
    Szanto, J.
    Lutz, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
    Hess, V.
    Pratsch, S.
    Potthast, S.
    Lee, L.
    Winterhalder, R.
    Widmer, L.
    Cescato, C.
    Lohri, A.
    Jost, L.
    Stillhart, P.
    Pestalozzi, B.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2390 - 2395
  • [47] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [48] Phase II trial of oxaliplatin and gemcitabine in patients with malignant pleural or peritoneal mesothelioma
    Hare, E.
    Hesdorrfer, M. E.
    Leinwand, J.
    Batista, L.
    Taub, R. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, G. P.
    Oberg, A. L.
    Foster, N. R.
    Jaslowski, A.
    Flynn, P. J.
    Campbell, D.
    Hedrick, E.
    Gray, L.
    Grothey, A.
    Alberts, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Results of the phase I-II study of gemcitabine (GEM) in combination with oxaliplatin (OX) in patients (pts) with advanced non-small-cell lung cancer (NSCLC) and ovarian cancer (OC).
    Faivre, S
    Raymond, E
    Lokiec, F
    Monnerat, C
    Vicente-Azevedo, J
    Pautier, P
    Lhommé, C
    Kayitalire, L
    Armand, JP
    Le Chevalier, T
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
12345